Literature DB >> 19253483

Thai health technology assessment guideline development.

Yot Teerawattananon1, Usa Chaikledkaew.   

Abstract

Health Technology Assessment (HTA) is a comprehensive form of policy research that provides information on the consequences of the application of health technology. It is used primarily to guide health care resource allocation decisions. In Thailand, there is increasing impetus to use HTA information to allow more explicit and transparent health care priority setting. A previous study indicated that serious attention needed to be given to the quality of reporting and the use of information in the analyses. These problems could be reduced by setting up standard guidelines for conducting HTA to stimulate the provision of standardized, reliable and good quality information for policy makers. Nevertheless, Thailand has not yet set up such guidelines. This may lead to low quality evaluations. Therefore, the objective of this article was to describe the rationale for guideline development, supporting principles, guideline development process, sources of information, and future challenges for HTA.

Mesh:

Year:  2008        PMID: 19253483

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  10 in total

1.  Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.

Authors:  Sutat Kantito; Surasak Saokaew; Sukit Yamwong; Prin Vathesatogkit; Wisuit Katekao; Piyamitr Sritara; Nathorn Chaiyakunapruk
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

2.  Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Authors:  Mónica Hernández Alava; Allan Wailoo; Stephen Pudney; Laura Gray; Andrea Manca
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

3.  Cost-Utility Analysis Compared Between Radiotherapy Alone and Combined Surgery and Radiotherapy for Symptomatic Spinal Metastases in Thailand.

Authors:  Pasawat Taechalertpaisarn; Sirichai Wilartratsami; Pochamana Phisalprapa; Chayanis Kositamongkol; Achiraya Teyateeti; Panya Luksanapruksa
Journal:  Neurospine       Date:  2022-05-12

4.  Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population.

Authors:  Surasak Saokaew; Wichittra Tassaneeyakul; Ratree Maenthaisong; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

5.  Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in Thailand.

Authors:  Intira Jeannie Collins; John Cairns; Nicole Ngo-Giang-Huong; Wasna Sirirungsi; Pranee Leechanachai; Sophie Le Coeur; Tanawan Samleerat; Nareerat Kamonpakorn; Jutarat Mekmullica; Gonzague Jourdain; Marc Lallemant
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

6.  Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.

Authors:  Pochamana Phisalprapa; Siripen Supakankunti; Phunchai Charatcharoenwitthaya; Piyaporn Apisarnthanarak; Aphinya Charoensak; Chaiwat Washirasaksiri; Weerachai Srivanichakorn; Nathorn Chaiyakunapruk
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Adherence to the iDSI reference case among published cost-per-DALY averted studies.

Authors:  Joanna Emerson; Ari Panzer; Joshua T Cohen; Kalipso Chalkidou; Yot Teerawattananon; Mark Sculpher; Thomas Wilkinson; Damian Walker; Peter J Neumann; David D Kim
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

8.  Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa.

Authors:  Kawaldip Sehmi; Janet L Wale
Journal:  Front Med Technol       Date:  2022-02-24

9.  Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand.

Authors:  Waranya Rattanavipapong; Thanaboon Worakijthamrongchai; Budsadee Soboon; Vilawan Luankongsomchit; Mananchaya Kongmuangpuk; Wanrudee Isaranuwatchai; Yot Teerawattananon; Yongchai Nilanont
Journal:  BMJ Open       Date:  2022-09-27       Impact factor: 3.006

10.  Reference data among general population and known-groups validity among hypertensive population of the EQ-5D-5L in Vietnam.

Authors:  Vu Quynh Mai; Kim Bao Giang; Hoang Van Minh; Lars Lindholm; Sun Sun; Klas Göran Sahlen
Journal:  Qual Life Res       Date:  2021-08-09       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.